1. Introduction {#sec1-molecules-24-01936}
===============

It is a common procedure to obtain two or more herbal materials from different parts of the same medicinal plant. Lonicera Lonicerae japonicae flos (LJF) and Lonicera Lonicerae japonicae caulis (LJC) are typical representatives of this. They are derived from different parts of *Lonicera japonica* Thunb., which belongs to the Caprifoliaceae family. LJF is originated from the dried buds and flowers, while LJC is derived from the dried stems. They are commonly referred to as "jin-yin-hua" and "ren-dong-teng" respectively, as independent Chinese material medica in the Chinese Pharmacopoeia (2015 edition, Volume I) and possess various pharmacological actions, such as anti-inflammatory \[[@B1-molecules-24-01936],[@B2-molecules-24-01936],[@B3-molecules-24-01936],[@B4-molecules-24-01936]\], anti-oxidant \[[@B5-molecules-24-01936]\], hepatoprotective \[[@B6-molecules-24-01936]\], anti-bacterial \[[@B7-molecules-24-01936]\], anti-viral \[[@B8-molecules-24-01936]\], anti-tumor \[[@B9-molecules-24-01936]\], immunity enhancement \[[@B10-molecules-24-01936]\] and other biological activities.

In the past decades, the great majority of literature about *L*. *japonica* has focused on identifying chemical compounds, quality control, and pharmacological action \[[@B11-molecules-24-01936],[@B12-molecules-24-01936],[@B13-molecules-24-01936],[@B14-molecules-24-01936],[@B15-molecules-24-01936]\]. More than 200 compounds such as flavonoids, organic acid, iridoids, saponins and volatile oil have been identified in *L*. *japonica*, and these active ingredients greatly contribute to its excellent function in the clinic \[[@B16-molecules-24-01936],[@B17-molecules-24-01936],[@B18-molecules-24-01936],[@B19-molecules-24-01936]\]. Phenolic acids, especially chlorogenic acid and caffeic acid, are regarded as the main anti-inflammatory active ingredients. Chlorogenic acid also has excellent anti-tumor, anti-oxidant and hepatoprotective activities. The activities of flavonoids include anti-oxidant, anti-bacterial and anti-tumor ones. A large number of studies also indicated that protocatechuic acid, chlorogenic acid and luteolin have anti-tumor activities \[[@B20-molecules-24-01936],[@B21-molecules-24-01936]\]; loganin and morroniside have neuroprotective \[[@B22-molecules-24-01936],[@B23-molecules-24-01936]\], anti-thrombotic and anti-coagulant effects. Loganin and sweroside exhibit analgesic and anti-inflammatory activities \[[@B24-molecules-24-01936]\]; Inosine may prove to be beneficial in the treatment of rheumatic heart disease, acute and chronic hepatitis. Although the efficacy of LJF and LJC described in the current Chinese Pharmacopoeia is different, the reason for these differences remains unclear. At present, more attention is paid to the quality control and chemical composition with less attention to the relation to traditional efficacy, resulting in the lack of material basis research relating chemical compositions and traditional efficacies.

The determination of single or several bioactive compounds in herbal medicines is one-sided, which might incompletely represent its intrinsic quality because the wholeness of traditional Chinese medicines (TCMs) means multi-components at multi-targets. Then, the development of hyphenated chromatography technique makes the simultaneous analysis of numerous constituents in short time possible \[[@B25-molecules-24-01936],[@B26-molecules-24-01936],[@B27-molecules-24-01936]\]. Hence, the aim of this study is to explore the difference of synthesis and accumulation of metabolites in the flowers and the caulis of *L. japonica* based on simultaneous determination of multiple bioactive compounds combined with multivariate statistical analysis. A reliable and accurate method based on the ultra-fast liquid chromatography tandem triple quadrupole mass spectrometry (UFLC-QTRAP-MS/MS) have been developed for the simultaneous determination of 47 bioactive constituents, including 12 organic acids, 12 flavonoids, six iridoids,13 amino acids and four nucleosides in 44 batches of LJF and LJC. In addition, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA) and *t*-test have been performed to classify the samples and reveal the differential compositions between LJF and LJC according to the contents of the tested constituents. Our findings not only provide a basis for the comprehensive evaluation and intrinsic quality control of LJF and LJC, but also pave the way for discovering the material basis contributing to the different properties and efficacies of the two medicinal materials at the phytochemical level.

2. Results {#sec2-molecules-24-01936}
==========

2.1. Optimization of Extraction Conditions {#sec2dot1-molecules-24-01936}
------------------------------------------

In order to achieve the optimal extraction conditions, three factors combining the previous experiences with the nature of the components had been chosen to be investigated and optimized. three parameters setting as follows: extraction solvents (100% methanol, 70% methanol, and 25% methanol), solvent to sample ratios (20:1, 40:1, and 60:1 (*v/w*)) and extraction time (20 min, 40 min, and 60 min), which might have both positive and negative effects on the extraction efficiency. The results revealed that the extraction efficiency of 70% methanol was similar to that of 100% methanol. With comprehensive consideration of the properties of the detected compounds, 70% methanol was chosen as extraction solvents. Moreover, ultrasonic extraction with solvent to sample ratio 40:1 for 45 min was sufficient and appropriate for the analysis. Therefore, the optimal extraction conditions were ultrasonic extraction with a 40:1 ratio of 70% methanol for 45 min at room temperature.

2.2. Optimization of UFLC Conditions {#sec2dot2-molecules-24-01936}
------------------------------------

Three types of columns: (X Bridge R C~18~ (4.6 mm × 100 mm, 3.5 μm) (Waters, Wexford, Ireland), Agilent ZORBAX SB C~18~ column (250 mm × 4.6 mm, 5 μm) (Agilent, Palo Alto, CA, USA)and Thermo Acclaim TM RSLC 120 C~18~ (150 mm × 2.1 mm, 2.2 μm) (Thermo Scientific, Waltham, MA, USA), different mobile phases (water/acetonitrile, water/methanol, 0.1% aqueous formic acid/ acetonitrile, 0.2% aqueous formic acid/0.2% formic acid acetonitrile), different flow rates (0.3 mL/min, 0.8 mL/min, 1.0 mL/min), and column temperatures (25 °C, 30 °C, and 35 °C) were all compared to test samples. The results of UFLC showed that the column of X Bridge R C~18~ (4.6 mm × 100 mm, 3.5 μm) (Waters, Wexford, Ireland) was better because of the strong hydrophilicity of organic acids, amino acids and nucleosides. Water-acetonitrile system had better resolution than water-methanol system. And when the mobile phase was added with formic acid, the shape and symmetry of chromatographic peak of organic acids were significantly improved. Finally, 0.2% aqueous formic acid-0.2% formic acid acetonitrile at a flow rate of 0.8 mL/min under the column temperature of 30 °C was selected and applied.

2.3. Optimization of MS Conditions {#sec2dot3-molecules-24-01936}
----------------------------------

The individual solutions of all standard compounds (about 100 ng/mL) were examined with the electro spray ionization (ESI) source in the positive and negative ion modes. The most abundant fragment ions were chosen as MRM transition from MS/MS spectrum; All the optimum values including retention time (t~R~), precursor and product ions, De-clustered Voltage (DP) and collision energy (CE) of each compound are summarized in [Table 1](#molecules-24-01936-t001){ref-type="table"} and the chromatograms with MRM mode are presented in [Figure S1](#app1-molecules-24-01936){ref-type="app"}. After trial and error inspection, we found that kaempferol-3-O-rutinoside, amino acids and nucleosides had higher sensitivity and intensity in positive ion mode. As shown in [Table 1](#molecules-24-01936-t001){ref-type="table"}, chlorogenic acid, neochlorogenic acid and cryptochlorogenic acid as isomer; isochlorogenic acid A, isochlorogenic acid B, isochlorogenic acid C and 1,3-*O*-dicaffeoylquinic acid as isomer; hyperoside, isoquercitrin as isomer; luteoloside, astragalin as isomer; L-leucine, L-isoleucine as isomer; lonicerin, kaempferol-3-*O*-rutinoside as isomer; they have the same precursor ion-product ion pairs, respectively. Thus, those standard substances were sequentially injected into QTRAP-MS/MS in turn to determine the compound according to the retention time.

2.4. Analytical Method Validation {#sec2dot4-molecules-24-01936}
---------------------------------

The detail of validation results of the method were presented in [Table 2](#molecules-24-01936-t002){ref-type="table"}. The standard calibration curves showed good determination coefficients (*r* \> 0.9990) of all the analytes. The limits of detections (LODs) and limits of quantifications (LOQs) ranged from 0.0050--139.226 ng/mL and 0.015--417.797 ng/mL, respectively. The RSD values of intra-day, inter-day of the 47 analytes ranged from 0.58--4.28% and 0.63--4.68%, respectively. The values of repeatability, stability test of the 47 components were all less than 5%, and the mean recoveries varied between 93.89% and 104.13%, with the RSD% less than 4.88%, which verified the effectiveness of the proposed method.

2.5. Quantitative Analysis of Samples {#sec2dot5-molecules-24-01936}
-------------------------------------

The sample information is listed in [Table 3](#molecules-24-01936-t003){ref-type="table"}. The validated analytical method was employed to assay 47 analytes in 44 batches of samples. The results of contents of 47 analytes are summarized in [Table S1](#app1-molecules-24-01936){ref-type="app"}. The histogram ([Figure 1](#molecules-24-01936-f001){ref-type="fig"}) illustrated that the contents of 47 analytes in LJF were higher than LJC apparently. And organic acids were the most abundant constituents among LJF. However, the percentages of the content of iridoids were bigger in LJC than LJF. From the results of the test data, we can know that the contents of isochlorogenic acid A, chlorogenic acid, neochlorogenic acid, quinic acid, luteoloside, luteolin and L-proline were relatively higher in LJF. Regardless of the organic acids or flavonoids, the measured contents of LJF are all exceeding the ones in LJC. Furthermore, loganin has significantly high content of LJC. therefore, it is considered as a characteristic component of LJC in current Chinese Pharmacopoeia. By comparing these parameters, it could be found that the contents and constituents of LJF and LJC were quite different.

2.6. PCA of Samples {#sec2dot6-molecules-24-01936}
-------------------

Unsupervised principal component analysis (PCA) was performed to distinguish and assess the quality of LJF and LJC. The measured contents (μg/g) of 47 compounds were set as variables. The scores plot was displayed in [Figure 2](#molecules-24-01936-f002){ref-type="fig"}., which showed a clear variation in two principal components (PC1, PC2). In terms of PCA analysis, the samples were divided into two clusters (LJF and LJC), which indicated that the composition and contents of LJF were quite different from LJC. The two principal components accumulatively accounted for 84%, This showed that the two principal components can fully reflect the overall information.

2.7. PLS-DA of the Samples {#sec2dot7-molecules-24-01936}
--------------------------

In order to find the potential chemical markers that had a significant impact on sample discrimination, the partial least squares discriminant analysis (PLS-DA) and variable importance in the projection (VIP) tests were performed. The PLS-DA scores plot and VIP values are shown in [Figure 3](#molecules-24-01936-f003){ref-type="fig"}a,b. LJF and LJC also were separated into two groups. Thereby indicated the remarkable differences of chemical constitutes between LJF and LJC. The specific parameters set as follows: confidence level was 95%, R2Y = 0.962 and Q2 = 0.935.

VIP indicates the importance of variables to the model. It describes the overall contribution of each variable to the model and the threshold is usually set to VIP \> 1. In this experiment, the VIP-values were obtained from PLS-DA processed data. Among them, VIP \> 1 indicates important variables, which could be regarded as potential markers that contribute greatly to the classification of these samples, such as isochlorogenic acid A (**1**), chlorogenic acid (**6**), neochlorogenic acid (**7**), quinic acid (**10**), secologanic acid (**26**), loganin (**27**), secoxyloganin (**28**), morroniside (**30**) and L-isoleucine (**36**).

2.8. t-test of Samples {#sec2dot8-molecules-24-01936}
----------------------

A *t*-test was used to verify the occurring probability of the differences. According to the *t*-test ([Figure 4](#molecules-24-01936-f004){ref-type="fig"}), the quantitative constituents in this experiment revealed a remarkable difference between LJF and LJC, except for protocatechuic acid, apigenin, sweroside, L-serine. The content of isochlorogenic acid A, neochlorogenic acid, quinic acid, rutin, hyperoside, luteoloside, lonicerin, kaempferol-3-O-rutinoside, isoquercitrin, secologanic acid, secoxyloganin and L-proline had strikingly higher level (*p* \< 0.01) in LJF compared with LJC. While, quantitation of loganin, 1,3-*O*-dicaffeoylquinic acid, sweroside and loganin acid displayed super high level (*p* \< 0.01) in LJC. Luteoloside and loganin were identified as the most effective chemical markers to evaluate the quality of LJF and LJC respectively, which is the same as the record of Chinese Pharmacopoeia.

3. Discussion {#sec3-molecules-24-01936}
=============

In this study, a sensitive and efficient method was developed and validated to explore the difference of synthesis and accumulation of metabolites in the flower and the caulis of *L*. japonica based on simultaneous determination of multiple bioactive constituents combined with multivariate statistical analysis. The results of PCA, PLS-DA and *t*-test were almost consistent, indicating that UFLC-QTRAP-MS/MS method combined with multivariate statistical analysis might be successful for quality evaluation of TCMs. In this method, precursor and product ion monitoring not only increase the specificity of detection but also help to identify the molecules. This can overcome the deficiencies of traditional methods and effectively reveal the complexity of samples ingredients.

From [Figure 3](#molecules-24-01936-f003){ref-type="fig"}b, the VIP-value of compounds **7**, **10**, **26**, **27**, **28**, **30**, **36** is close, with a range of 1.25--2.5. While, for compounds **1** and **6** VIP is \> 3. Isochlorogenic acid A (**1**) and chlorogenic acid (**6**) are phenolic acids. It is widely recognized that phenolic acids is the primary active components, and among them, chlorogenic acid is the major ingredient for a wide range of pharmacological activities \[[@B2-molecules-24-01936],[@B3-molecules-24-01936],[@B4-molecules-24-01936],[@B28-molecules-24-01936],[@B29-molecules-24-01936]\] and its content has been used as the main indicator for evaluating the quality of LJF; While, in the Chinese Pharmacopoeia chlorogenic acid also recorded as a marker of LJC. This might be the material basis of their common efficacy of "qing-re-jie-du". However, the standard of content in LJC is 15 times lower than that of LJF. And the PLS-DA and VIP results of indicated the chlorogenic acid could be considered as a potential marker distinguish between LJF and LJC, which is consistent with the Chinese Pharmacopoeia record. Generally, different compounds and different types of compounds have different pharmacological effects. The results of quantitative analysis may provide the support for elucidating the similarities and differences in the efficacy of LJF and LJC from the perspective of phytochemistry.

4. Materials and Methods {#sec4-molecules-24-01936}
========================

4.1. Plant Materials {#sec4dot1-molecules-24-01936}
--------------------

The forty-four sample batches were from different habitats and commercial herbs. Detailed information on these samples is listed in [Table 3](#molecules-24-01936-t003){ref-type="table"}. The botanical origins of materials were authenticated by one of the authors, Prof. Xunhong Liu. Voucher specimens were deposited at the Herbarium in Nanjing University of Chinese Medicine. The samples were collected in 2018, samples 1--16 are Lonicerae japonicae caulis, and samples 17--44 are Lonicerae japonicae flos.

4.2. Chemicals and Reagents {#sec4dot2-molecules-24-01936}
---------------------------

Forty-seven chemical standards were obtained: isochlorogenic acid A (**1**), isochlorogenic acid B (**2**), isochlorogenic acid C (**3**), 1,3-*O*-dicaffeoylquinic acid (**4**), 4,5-*O*-dicaffeoylquinic acid methyl ester (**5**), chlorogenic acid (**6**), neochlorogenic acid (**7**), cryptochlorogenic acid (**8**), caffeic acid (**9**), quinic acid (**10**), protocatechuic acid (**11**), ferulic acid (**12**), rutin (**13**), hyperoside (**14**), luteoloside (**15**), luteolin (**16**), rhoifolin (**17**), diosmetin (**18**), apigenin (**19**), kaempferol (**20**), astragalin (**21**), lonicerin (**22**), kaempferol-3-*O*-rutinoside (**23**), isoquercitrin (**24**), sweroside (**25**), secologanic acid (**26**), loganin (**27**), secoxyloganin (28), loganin acid (**29**), morroniside (**30**), L-alanine (**31**), L-serine (**32**), L-proline (**33**), L-valine (**34**), L-threonine (**35**), L-isoleucine (**36**), L-leucine (**37**), L-aspartic acid (**38**), L-glutamate (**39**), L-lysine (**40**), L-histidine (**41**), L-phenylalanine (**42**), L-arginine (**43**), cytidine (**44**), uridine (**45**), adenosine (**46**) and inosine (**47**). The purity of all standards components was determined to be more than or equal to 98% by HPLC analysis. The structure of the standard substance is showed in [Figure S2](#app1-molecules-24-01936){ref-type="app"}. Among them **1**, **2**, **6**--**9**, **12**, **27** and **31**-**47** were obtained from Shanghai Yuanye Biotechnology Co. Ltd. (Shanghai, China); **3**, **4**, and **11** were received from Chengdu Prefa Technology Development Co. Ltd. (Sichuan, China); **5**, **15**--**17**, **22**, **26** and **29** were provided by Liangwei Chemical Reagent Co. Ltd. (Nanjing, China); **10**, **13**, **14**, **21** and **24** were purchased from the Department of Control of Pharmaceutical and Biological Products (Beijing, China); **18**--**20**, **23**, **25** and **30** were offered by Chengdu Chroma Biotechnology Co. Ltd. (Sichuan, China); **28** was acquired from Nanjing Jingzhu Biotechnology Co. Ltd. (Nanjing, China). Chromatographic grade methanol and acetonitrile were purchased from Merck (Darmstadt, Germany); other analytical grade solvents were purchased from Liangwei Chemical Reagent Co. Ltd. (Nanjing, China). Ultrapure water was obtained from a Milli-Q purification system (Millipore, Bedford, MA, USA).

4.3. Preparation of Sample Solutions {#sec4dot3-molecules-24-01936}
------------------------------------

The samples were ground into powder (50 meshes). Accurately weighed powder samples (1.0 g) were extracted by ultra-sonication in 40 mL 70% methanol for 45 min, then cooled to room temperature; The extraction solution was allowed to be cooled and weighed again, the loss of solvent was replenished with 70% methanol and mixed well. After centrifugation (8050 g, 10 min) and filtered (0.22 μm membrane filters), the supernatants were stored in a sample bottle at 4 °C prior to injection LC-MS.

4.4. Preparation of Standard Solutions {#sec4dot4-molecules-24-01936}
--------------------------------------

The following amounts of each sample in mg/mL were used to prepare standard solutions: (**1**) 10.06, (**2**) 1.09, (**3**) 1.19, (**4**) 1.18, (**5**) 1.09, (**6**) 10.09, (**7**) 10.06, (**8**) 5.05, (**9**) 1.22, (**10**) 10.01, (**11**) 1.12, (**12**) 0.96, (**13**) 1.26, (**14**) 1.33, (**15**) 1.16, (**16**) 5.09, (**17**) 1.42, (**18**) 1.09, (**19**) 4.93, (**20**) 1.08, (**21**) 0.99, (**22**) 1.09, (**23**) 1.02, (**24**) 1.06, (**25**) 5.08, (**26**) 5.04, (**27**) 5.08, (**28**) 5.07, (**29**) 5.07, (**30**) 5.10, (**31**) 5.09, (**32**) 5.09, (**33**) 5.09, (**34**) 1.02, (**35**) 1.06, (**36**) 0.83, (**37**) 1.00, (**38**) 1.02, (**39**) 0.76, (**40**) 0.57, (**41**) 1.10, (**42**) 1.08, (**43**) 0.88, (**44**) 1.25, (**45**) 1.02, (**46**) 1.12, (**47**) 1.15. All solutions were stored at 4 °C, then filtered through 0.22 μm membranes (Jinteng Laboratory Equipment, Tianjin, China) before analysis.

4.5. UFLC-QTRAP-MS/MS Instrumentation and Conditions {#sec4dot5-molecules-24-01936}
----------------------------------------------------

All samples were analyzed using UFLC system (Shimadzu Corp., Kyoto, Japan) coupled with a triple quadrupole-linear ion trap mass spectrometer (QTRAP-5500) (AB SCIEX, Framingham, MA, USA). The ESI-MS spectra were acquired in the multiple reaction monitoring (MRM) under both positive and negative ion modes. The MS parameters were setting as follows: gas temperature 550 °C; the ion spray voltage was set to 5500 V (positive) and −4500 V (negative), respectively; gas temperature 550 °C; GS1 flow 55 L/min; GS2 flow 55 L/min; CUR flow 40 L/min; all MS data were acquired and analyzed using the Analyst 1.6.2 software. The cone voltage and collision energy parameter of each compound was individually optimized. Separation was performed using the X Bridge R C~18~ column (4.6 mm × 100 mm, 3.5 μm) (Waters, Wexford, Ireland). The mobile phase was composed of 0.2% aqueous formic acid (A) and acetonitrile with 0.2% formic acid (B) at the flow rate of 0.8 mL/min. The injection volume was 1 μL. The gradient elution as follows: 0--5 min: 2% B; 5--10 min: 2--13% B; 10--12 min: 13% B; 12--17 min: 13--25% B; 17--25 min: 25--33% B; 25--27 min: 33--35% B; 27--29 min: 35--50% B; 29--31 min: 50--95% B. The re-equilibration time was 4 min.

4.6. Validation of UFLC-QTRAP-MS/MS Method {#sec4dot6-molecules-24-01936}
------------------------------------------

The analysis method was validated for linearity and range, detection limit (LOD), limit of quantitation (LOQ), precision (intra-day and inter-day), repeatability, stability and accuracy according to the guidelines of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Q2 analytical validation. The mixed standard stocked solution containing forty -four reference substances was serially diluted with 70% methanol to required concentrations for the establishment of calibration curves. The LODs and LOQs of these analytes under the present chromatographic conditions were determined at signal-to-noise (S/N) ratio equaled to 3 and 10, respectively. The precision of the method was evaluated by determining the 47 analytes in six replications during one day and by duplicating the experiments on three consecutive days. Six independent sample solutions from the same sample were parallelly processed and analyzed to ensure the repeatability. The same sample solution was injected at 0, 2, 4, 8, 12 and 24 h to investigate the stability of the instrument, respectively. A recovery test was used to check the accuracy of the method. Recovery values were calculated by the formula: (%) = (found amount -- original amount in sample)/spiked amount × 100%.

4.7. Multivarite Statistical Analysis {#sec4dot7-molecules-24-01936}
-------------------------------------

In order to observe the classification and assess the variations of LJF and LJC, the data of 47 analytes were used to carry out PCA and PLS-DA using the SIMCA-P 13.0 software (Umetrics AB, Umea, Sweden). PCA is an unsupervised pattern recognition method, which is used to visualize similarities or differences in multivariate data. It has been widely used in the differentiation and identification of medicinal materials. PLS-DA was excellent for highlighting the differences between two groups. *t*-test is utilized to confirm that there were differences in chemical composition between LJF and LJC (SPSS 16.0 for Windows, IBM, Armonk, NY, USA). Data of the contents of 47 compounds in the 44 batches of samples are listed in [Table S1](#app1-molecules-24-01936){ref-type="app"}. When the contents of investigated components were below the quantitation limit or not detected in the samples, the values of such elements were considered to be 0.

5. Conclusions {#sec5-molecules-24-01936}
==============

In the present study, an optimized UFLC-QTRAP-MS/MS assay has been successfully applied to simultaneous determination of 47 bioactive constituents, including 12 organic acids, 12 flavonoids, six iridoids, 13 amino acids and four nucleosides in 44 batches of LJF and LJC samples from different habitats and commercial herbs. Furthermore, PCA, PLS-DA and *t*-test were performed to classify the samples and reveal the differential compositions between LJF and LJC according to the content of the tested constituents. The results showed that LJF and LJC were clearly classified and the sample classification were closely related to the different chemical constituents. (e.g., isochlorogenic acid A, chlorogenic acid, neochlorogenic acid, quinic acid, secologanic acid, luteoloside, loganin, secoxyloganin, morroniside and L-isoleucine). It demonstrated that the quantitative components in this experiment had remarkable differences between LJF and LJC based on *t*-test, except for protocatechuic acid, apigenin, sweroside and L-serine. The bioactivities of loganin, including neuroprotective \[[@B20-molecules-24-01936],[@B21-molecules-24-01936]\], anti-thrombotic and anti-coagulant effects, are consistent with the efficacy of loganin (the biomarker of LJC) recorded in the Chinese Pharmacopoeia. The content determination also illustrated that loganin in LJC accounted for a significantly higher percentage than that in LJF, while LJF was more abundant in luteoloside, leading to great influences on the different efficacy that LJF and LJC were separately better in "shu-san-feng-re" and "shu-feng-tong-luo". LJF and LJC are medicinal materials with different medicinal parts of the same origin. Although the types of chemical components are basically the same, their efficacy are different. Our findings not only provided a basis for the comprehensive evaluation and intrinsic quality control of LJF and LJC, but also paves the way for discovering the material basis contributing to the different properties and efficacies of the two medicinal materials at the phytochemical level.

**Sample Availability:** Samples of all compounds are available from the authors.

Figure S1: Multiple-reaction monitoring (MRM) chromatogram of 47 investigated compounds; Figure S2: The structure of the standard substances; Table S1: Contents of 47 constituents in samples of LJF and LFC.
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![Histogram of the accumulative contents of LJF and LJC from 44 batches (*X*-axis represents 44 batches of samples; *Y*-axis is the content (μg/g) of five types of compounds in each sample).](molecules-24-01936-g001){#molecules-24-01936-f001}

![Score scatter plot by PCA processed data acquired from samples. Each of the blue circle represented a batch of LJF, the green circle represented a batch of LJC.](molecules-24-01936-g002){#molecules-24-01936-f002}

![Score scatter plot (**a**) and VIP (**b**) by PLS-DA processed data obtained from LJF and LJC. Each of the blue circle represented a batch of LJF, the green circle represented a batch of LJC, each of the black circle represented a compound (see [Table 1](#molecules-24-01936-t001){ref-type="table"} for compound names).](molecules-24-01936-g003){#molecules-24-01936-f003}

![The contents of 47 compounds in samples. (**a**) organic acids, (**b**) flavonoids, (**c**) iridoids, (**d**) amino acids and nucleosides (*X*-axis 1--47 is the number of compounds, see [Table 1](#molecules-24-01936-t001){ref-type="table"} for compound names; *Y*-axis is the content (μg of compound/g)).](molecules-24-01936-g004){#molecules-24-01936-f004}

molecules-24-01936-t001_Table 1

###### 

Retention times and related mass spectrometry (MS) data of the target compounds.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   Name                                         Formula              (t~R~) (min)   \[M + H\]^+^\   \[M − H\]^−^\   MRM (Precursor→Product)   DP/V   CE/V
                                                                                         m/z             m/z                                              
  ----- -------------------------------------------- -------------------- -------------- --------------- --------------- ------------------------- ------ ------
  1     Isochlorogenic acid A                        C~25~H~24~O~12~      20.15          \-              515.45          515.1/191                 −85    −22

  2     Isochlorogenic acid B                        C~25~H~24~O~12~      20.13          \-              515.45          514.989/353               −80    −26

  3     Isochlorogenic acid C                        C~25~H~24~O~12~      20.27          \-              515.45          515.1/191                 −75    −24

  4     1,3-*O*-dicaffeoylquinic acid                C~25~H~24~O~12~      20.30          \-              515.45          514.980/190.979           −95    −24

  5     4,5-*O*-dicaffeoylquinic acid methyl ester   C~26~H~26~O~12~      29.50          \-              529.47          529.194/135.001           −85    −42

  6     Chlorogenic acid                             C~16~H~18~O~9~       18.75          \-              353.31          305.01/125                −35    −20

  7     Neochlorogenic acid                          C~16~H~18~O~9~       17.64          \-              353.31          305.01/125                −80    −26

  8     Cryptochlorogenic acid                       C~16~H~18~O~9~       19.86          \-              353.31          305.01/125                −95    −20

  9     Caffeic acid                                 C~9~H~8~O~4~         19.45          \-              179.16          179.03/134.6              −125   −20

  10    Quinic acid                                  C~7~H~12~O~6~        18.75          \-              191.17          191.099/84.981            −195   −28

  11    Protocatechuic acid                          C~7~H~6~O~4~         12.99          \-              153.12          152.9/109                 −85    −16

  12    Ferulic acid                                 C~10~H~10~O~4~       23.89          \-              193.18          193.017/134               −50    −10

  13    Rutin                                        C~27~H~30~O~16~      22.06          \-              609.52          609.06/300                −245   −46

  14    Hyperoside                                   C~21~H~20~O~12~      22.74          \-              463.38          463.003/299.9             −160   −36

  15    Luteoloside                                  C~21~H~20~O~11~      23.03          \-              447.38          447.117/284.963           −300   −36

  16    Luteolin                                     C~15~H~10~O~6~       29.53          \-              285.24          285.086/132.980           −170   −40

  17    Rhoifolin                                    C~27~H~30~O~14~      24.82          \-              577.52          577.185/268.958           −65    −46

  18    Diosmetin                                    C~16~H~12~O~6~       30.88          \-              299.26          298.938/283.929           −215   −30

  19    Apigenin                                     C~15~H~10~O~5~       30.74          \-              269.24          268.8/116.9               −129   −40

  20    Kaempferol                                   C~15~H~10~O~6~       30.88          \-              285.24          285.0/116.9               −120   −36

  21    Astragalin                                   C~21~H~20~O~11~      24.40          \-              447.38          447.1/283.9               −100   −36

  22    Lonicerin                                    C~27~H~30~O~15~      23             \-              593.52          593.146/283.984           −200   −54

  23    Kaempferol-3-O-rutinoside                    C~27~H~30~O~15~      23.59          595.5           \-              595/287.2                 36     25

  24    Isoquercitrin                                C~21~H~20~O~12~      22.50          \-              464.38          463.015/300               −180   −36

  25    Sweroside                                    C~16~H~22~O~9~       20.14          \-              358.34          357.213/124.985           −65    −20

  26    Secologanic acid                             C~16~H~22~O~10~      19.17          \-              376.36          357.107/212.956           −170   −22

  27    Loganin                                      C~17~H~26~O~10~      19.72          \-              390.38          389.262/226.980           −40    −12

  28    Secoxyloganin                                C~17~H~24~O~11~      21.10          \-              404.37          403.219/120.973           −135   −32

  29    Loganin acid                                 C~16~H~24~O~10~      18.07          \-              376.36          375.107/212.956           −170   −22

  30    Morroniside                                  C~17~H~26~O~11~      18.53          \-              406.38          405.235/243               −100   −14

  31    [l]{.smallcaps}-Alanine                      C~3~H~7~NO~2~        1.38           90.09           \-              90.06/44.02               100    10

  32    [l]{.smallcaps}-Serine                       C~3~H~7~NO~3~        1.38           106.09          \-              106.05/59.99              100    8

  33    [l]{.smallcaps}-Proline                      C~5~H~9~NO~2~        1.65           116.13          \-              116.07/70.02              68     10

  34    [l]{.smallcaps}-valine                       C~5~H~11~NO~2~       2.32           118.15          \-              118.09/72.06              100    10

  35    [l]{.smallcaps}-Threonine                    C~4~H~9~NO~3~        1.38           120.12          \-              120.07/74                 100    20

  36    [l]{.smallcaps}-Isoleucine                   C~6~H~13~NO~2~       4.96           132.17          \-              132.1/86.05               64     10

  37    [l]{.smallcaps}-Leucine                      C~6~H~13~NO~2~       5.40           132.17          \-              132.1/86.05               100    16

  38    [l]{.smallcaps}-aspartic acid                C~4~H~7~NO~4~        1.38           134.10          \-              134.05/87.96              59     10

  39    [l]{.smallcaps}-Glutamate                    C~5~H~7~NO~4~        1.24           146.11          \-              147.08/83.92              100    16

  40    [l]{.smallcaps}-lysine                       C~6~H~14~N~2~O~2~    1.25           147.19          \-              147.11/83.91              100    14

  41    [l]{.smallcaps}-Histidine                    C~6~H~9~N~3~O~2~     1.24           156.15          \-              156.08/110.03             100    16

  42    [l]{.smallcaps}-Phenylalanine                C~9~H~11~NO~2~       13             166.19          \-              166.1/120.05              100    14

  43    [l]{.smallcaps}-Arginine                     C~6~H~14~N~4~O~2~    1.36           175.20          \-              175.12/70.02              100    18

  44    Cytidine                                     C~9~H~13~N~3~O~5~    1.65           244.22          \-              244.09/112                61     10

  45    Uridine                                      C~9~H~12~N~2~O~6~    4.25           245.20          \-              244.896/113               10     13

  46    Adenosine                                    C~10~H~13~N~5~O~4~   6.73           268.24          \-              268.1/136.07              86     23

  47    Inosine                                      C~10~H~12~N~4~O~5~   9.62           269.22          \-              269/137.07                46     15
  --------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Regression equations, limits of detections (LODs), limits of quantifications (LOQs), intra- and inter-day precisions, repeatability, stabilities, and recoveries of 47 compounds.

  Name                                         Regression Equation                *r*      Linear Range (ng/mL)   LOD (ng/mL)   LOQ (ng/mL)   Precision   Repeatability   Stability   Recovery            
  -------------------------------------------- ---------------------------------- -------- ---------------------- ------------- ------------- ----------- --------------- ----------- ---------- -------- ------
  Isochlorogenic acid A                        y = 1.02 × 10^3^x + 1.41 × 10^5^   0.9996   77.6--388,000          14.48         43.45         2.63        2.79            3.04        4.92       96.11    3.11
  Isochlorogenic acid B                        y = 602x + 1.45 × 10^5^            0.9995   7.63--38,200           2.10          6.28          3.95        4.39            0.59        1.12       96.07    4.11
  Isochlorogenic acid C                        y = 483x + 2.1 × 10^4^             0.9998   45--28,100             7.92          23.76         3.27        3.64            2.79        1.79       99.05    2.02
  1,3-*O*-dicaffeoylquinic acid                y = 5.78 × 10^3^x + 5.62 × 10^4^   0.9996   42--2630               6.97          20.91         3.44        3.28            2.49        2.07       98.95    4.75
  4,5-*O*-dicaffeoylquinic acid methyl ester   y = 9.67 × 10^3^x − 4.3 × 10^4^    0.9996   5.6--700               1.32          3.96          3.79        4.10            1.01        1.36       94.57    3.98
  Chlorogenic acid                             y = 845x + 4.77 × 10^5^            0.9999   0.604--755,000         0.20          0.59          1.78        1.79            0.70        0.51       99.48    0.62
  Neochlorogenic acid                          y = 115x + 1.13 × 10^5^            0.9992   3.01--376,000          0.39          1.16          1.83        1.71            1.77        4.55       98.25    1.70
  Cryptochlorogenic acid                       y = 878x + 6.7 × 10^3^             0.9993   0.316--79,000          0.09          0.27          4.04        4.31            2.41        4.75       96.61    3.62
  Caffeic acid                                 y = 2.49 × 10^3^x + 1.69 × 10^5^   0.9998   5.76--7200             1.17          3.51          2.86        3.17            3.19        4.91       95.76    3.05
  Quinic acid                                  y = 1.19 × 10^3^x + 3.05 × 10^5^   0.9996   19.6--245,000          5.13          15.39         2.73        2.38            2.26        1.74       96.52    3.68
  Protocatechuic acid                          y = 6.13 × 10^3^x + 1.95 × 10^5^   0.9994   7.68--960              0.78          2.34          2.50        2.30            1.46        3.31       96.71    4.02
  Ferulic acid                                 y = 121x + 3.68 × 10^3^            0.9990   11.2--1400             2.81          8.44          4.21        3.96            0.87        2.57       102.08   4.88
  Rutin                                        y = 2.5 × 10^3^x + 3.14 × 10^5^    0.9998   0.979--12,200          0.04          0.11          2.91        3.21            1.70        1.00       97.17    2.94
  Hyperoside                                   y = 4.32 × 10^3^x + 1.77 × 10^5^   0.9995   0.265--3313            0.06          0.17          1.69        1.55            4.12        2.50       96.67    4.07
  Luteoloside                                  y = 1.07 × 10^3^x + 1.34 × 10^5^   1.000    0.664--41,500          0.06          0.17          1.03        0.92            4.91        4.01       104.13   4.73
  Luteolin                                     y = 100x + 2.47 × 10^3^            0.9995   124--15,600            10.15         30.45         2.28        2.22            3.13        1.89       101.81   3.68
  Rhoifolin                                    y = 1.08 × 10^4^x + 572            0.9999   1.3--162               0.28          0.84          2.53        2.75            3.08        4.44       99.63    4.74
  Diosmetin                                    y = 1.15 × 10^4^x − 9.93 × 10^3^   0.9993   1.72--214              0.15          0.44          1.09        0.78            0.84        0.47       95.63    1.14
  Apigenin                                     y = 2.17 × 10^4^x − 9.13 × 10^4^   0.9995   25.4--318              4.19          12.56         3.54        3.83            4.22        4.39       99.03    3.61
  Kaempferol                                   y = 191x + 250                     0.9997   2.02--101              0.57          1.70          4.28        4.68            3.78        3.06       101.42   4.49
  Astragalin                                   y = 2.17 × 10^4^x + 8.73 × 10^4^   0.9999   0.0353--883            0.01          0.02          3.51        3.92            3.77        3.38       97.79    1.74
  Lonicerin                                    y = 1.11 × 10^3^x + 4.25 × 10^3^   0.9994   22.4--14,000           0.02          0.07          3.45        3.85            4.12        4.41       97.77    3.43
  Kaempferol-3-*O*-rutinoside                  y = 3.13 × 10^3^x + 9.11 × 10^4^   0.9999   0.632--7900            0.04          0.12          2.31        2.44            3.43        3.62       97.66    1.64
  Isoquercitrin                                y = 4.33 × 10^3^x + 1.4 × 10^5^    0.9996   2.65--3310             0.20          0.58          1.68        1.54            3.81        2.59       96.34    3.33
  Sweroside                                    y = 34.9x + 1.56 × 10^3^           0.9996   0.841--52,600          0.23          0.69          3.54        3.68            3.09        4.67       96.80    3.12
  Secologanic acid                             y = 609x + 3.48 × 10^4^            0.9999   1.45--182,000          0.07          0.22          3.02        3.37            3.84        1.08       96.41    2.98
  Loganin                                      y = 3.95x + 1.72 × 10^3^           0.9990   14.1--35,200           4.18          12.54         2.26        2.43            0.37        0.30       98.00    1.84
  Secoxyloganin                                y = 638x + 1.32 × 10^5^            0.9990   0.189--47,400          0.05          0.16          4.19        4.67            3.16        1.61       98.00    1.70
  Loganin acid                                 y = 1.11 × 10^3^x − 1.98 × 10^5^   0.9993   441.2--22,100          139.27        417.80        2.95        2.54            2.49        1.77       97.33    0.66
  Morroniside                                  y = 10.4x + 8.21 × 10^3^           0.9990   41.1--514,000          7.87          23.60         2.11        1.83            4.69        4.08       97.12    3.21
  [l]{.smallcaps}-Alanine                      y = 1.43 × 10^3^x + 1.78 × 10^4^   0.9997   8.47--10,600           2.23          6.68          3.07        2.60            2.98        4.81       101.09   4.66
  [l]{.smallcaps}-Serine                       y = 351x + 5.93 × 10^4^            0.9997   9.16--11,500           1.34          4.03          2.71        2.54            2.48        4.23       97.96    4.32
  [l]{.smallcaps}-Proline                      y = 1.77 × 10^3^x + 3.04 × 10^4^   0.9996   0.381--23,800          0.09          0.28          2.75        2.86            1.65        3.58       97.09    2.70
  [l]{.smallcaps}-Valine                       y = 6.36 × 10^3^x + 2.17 × 10^5^   0.9995   2.51--1570             0.22          0.64          2.96        3.19            1.40        1.40       97.25    2.09
  [l]{.smallcaps}-Threonine                    y = 1.75 × 10^3^x − 9.1 × 10^4^    0.9996   111--13,900            22.33         66.98         2.83        1.46            0.60        1.35       96.26    2.69
  [l]{.smallcaps}-Isoleucine                   y = 5.15 × 10^3^x + 1.92 × 10^5^   0.9998   2.88--3600             0.42          1.27          0.67        0.63            2.10        1.17       95.31    1.88
  [l]{.smallcaps}-Leucine                      y = 9.64 × 10^3^x + 4.72 × 10^5^   0.9997   3.38--4230             0.71          2.13          1.21        1.28            1.93        0.89       93.89    3.10
  [l]{.smallcaps}-Aspartic acid                y = 660x + 2.38 × 10^4^            0.9991   4.6--57,500            0.84          2.51          1.49        1.66            1.15        4.09       97.55    2.99
  [l]{.smallcaps}-Glutamate                    y = 1.64 × 10^3^x − 2.82 × 10^5^   0.9998   474--29,600            136.18        408.53        0.69        0.74            2.09        0.93       97.89    1.72
  [l]{.smallcaps}-Lysine                       y = 2.32 × 10^3^x − 2.01 × 10^5^   0.9993   147--12,600            36.78         110.34        0.58        0.65            2.48        0.73       98.52    1.66
  [l]{.smallcaps}-Histidine                    y = 7.11 × 10^3^x + 1.65 × 10^5^   0.9999   59.1--7390             7.66          22.97         1.67        1.45            3.66        1.42       96.14    3.31
  [l]{.smallcaps}-Phenylalanine                y = 1.7 × 10^4^x + 2.55 × 10^5^    0.9997   25.6--3200             0.55          1.65          1.78        1.28            1.21        0.43       103.21   4.27
  [l]{.smallcaps}-Arginine                     y = 6.54 × 10^3^x + 1.21 × 10^5^   0.9996   0.241--1510            0.04          0.13          1.25        1.19            2.98        1.17       97.99    2.55
  Cytidine                                     y = 4.72 × 10^4^x − 1.94 × 10^4^   0.9995   1.84--230              0.50          1.49          3.39        3.20            1.26        3.93       96.29    3.54
  Uridine                                      y = 861x + 7.0 × 10^3^             0.9997   40.4--5050             7.12          21.37         3.2         3.53            1.31        3.38       98.06    1.71
  Adenosine                                    y = 5.28 × 10^4^x + 3.05 × 10^5^   0.9994   6.31--789              0.95          2.83          1.45        1.41            0.69        0.25       98.61    3.49
  Inosine                                      y = 7.98 × 10^3^x + 2.12 × 10^4^   0.9991   8.78--220              1.85          5.54          1.73        1.87            1.26        2.43       95.89    2.89
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###### 

Detailed information of samples.

  Species                      No.   Batch No.     Habits     Origin
  ---------------------------- ----- ------------- ---------- -------------------------------------------------------------------
  Lonicerae japonicae caulis   S1    180810        Shandong   Ningbo Mingbei traditional Chinese Medicine Co., Ltd.
                               S2    20170927      Shandong   Nantong Sanyue Herbal Medicine Co., Ltd.
                               S3    20170801      Shandong   Local collection
                               S4    171020        Jiangsu    Shanghai medicine holdings Yixing Co., Ltd.
                               S5    170501        Shandong   Local collection
                               S6    170601        Shandong   Anhui YaoZhiyuan traditional Chinese Medicine decoction Co., Ltd.
                               S7    180501        Shandong   Bozhou Beshixin traditional Chinese Medicine slice Co., Ltd.
                               S8    1805011       Shandong   Bozhou Beshixin traditional Chinese Medicine slice Co., Ltd.
                               S9    18030825      Shandong   Anhui Dichang Pharmaceutical Co., Ltd.
                               S10   C16052001     Jiangsu    Zhejiang Yedong Pharmaceutical Co., Ltd.
                               S11   180426        Jiangsu    Nantong Sanyue Herbal Medicine Co., Ltd.
                               S12   20181104      Shandong   Local collection
                               S13   20181105      Shandong   Local collection
                               S14   20181103      Shandong   Local collection
                               S15   20181102      Shandong   Local collection
                               S16   20181101      Shandong   Local collection
  Lonicerae japonicae flos     S17   20181108      Shandong   Local collection
                               S18   180315        Shandong   Suzhou Boyuan pharmaceutical industry
                               S19   2018110506    Henan      Fengqiu
                               S20   2018110502    Shandong   Linyi
                               S21   180401        Henan      Anhui YaoZhiyuan traditional Chinese Medicine decoction Co., Ltd.
                               S22   2018110603    Henan      Fengqiu
                               S23   2018110604    Henan      Fengqiu
                               S24   2018110303    Hebei      Juluxian Goujijinyinhua market
                               S25   C16011901     Henan      Zhejiang Yedong Pharmaceutical Co., Ltd.
                               S26   20181109      Henan      Fengqiu
                               S27   180701        Shandong   Chongqing Wanli Pharmaceutical Co., Ltd.
                               S28   180315        Shandong   Suzhou Boyuan pharmaceutical industry
                               S29   2018110601    Henan      Fengqiu
                               S30                 Henan      Fengqiu
                               S31                 Henan      Fengqiu
                               S32   2018110505    Shandong   Linyi
                               S33   2018110302    Hebei      Juluxian Gouqijinyinhua market
                               S34   20181103021   Hebei      Juluxian Gouqijinyinhua market
                               S35   20181103022   Hebei      Juluxian Gouqijinyinhua market
                               S36   2018110301    Hebei      Juluxian Gouqijinyinhua market
                               S37   20181103012   Hebei      Juluxian Gouqijinyinhua market
                               S38   20181103013   Hebei      Juluxian Gouqijinyinhua market
                               S39   2018110504    Shandong   Linyi
                               S40   2018110503    Shandong   Linyi
                               S41   2018110303    Hebei      Juluxian Gouqijinyinhua market
                               S42   20181107      Shandong   Local herbal medicine market
                               S43   180607        Shandong   Nantong Sanyue Herbal Medicine Co., Ltd.
                               S44   170802        Shandong   Bozhou Beshixin traditional Chinese Medicine slice Co., Ltd.
